{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T09:41:27Z","timestamp":1773394887664,"version":"3.50.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,4,19]],"date-time":"2011-04-19T00:00:00Z","timestamp":1303171200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1007\/s11926-011-0181-y","type":"journal-article","created":{"date-parts":[[2011,4,18]],"date-time":"2011-04-18T07:12:17Z","timestamp":1303110737000},"page":"353-359","source":"Crossref","is-referenced-by-count":50,"title":["Synovitis in Psoriatic Arthritis: Immunohistochemistry, Comparisons With Rheumatoid Arthritis, and Effects of Therapy"],"prefix":"10.1007","volume":"13","author":[{"given":"Arno W. R.","family":"van Kuijk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul P.","family":"Tak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,4,19]]},"reference":[{"issue":"12","key":"181_CR1","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1093\/rheumatology\/keg384","volume":"42","author":"D Kane","year":"2003","unstructured":"Kane D, Stafford L, Bresnihan B, Fitzgerald O. A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience. Rheumatol Oxf. 2003;42(12):1460\u20138.","journal-title":"Rheumatol Oxf"},{"issue":"5","key":"181_CR2","first-page":"1041","volume":"28","author":"P Rahman","year":"2001","unstructured":"Rahman P, Nguyen E, Cheung C, Schentag CT, Gladman DD. Comparison of radiological severity in psoriatic arthritis and rheumatoid arthritis. J Rheumatol. 2001;28(5):1041\u20134.","journal-title":"J. Rheumatol."},{"issue":"1","key":"181_CR3","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0049-0172(73)90035-8","volume":"3","author":"JM Moll","year":"1973","unstructured":"Moll JM, Wright V. Psoriatic arthritis. Semin Arthritis Rheum. 1973;3(1):55\u201378.","journal-title":"Semin. Arthritis Rheum."},{"issue":"Suppl 2","key":"181_CR4","doi-asserted-by":"publisher","first-page":"ii3","DOI":"10.1136\/ard.2004.032318","volume":"64","author":"PS Helliwell","year":"2005","unstructured":"Helliwell PS, Taylor WJ. Classification and diagnostic criteria for psoriatic arthritis. Ann Rheum Dis. 2005;64 Suppl 2:ii3\u20138.","journal-title":"Ann. Rheum. Dis."},{"issue":"12","key":"181_CR5","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1093\/rheumatology\/keg445","volume":"42","author":"D Kane","year":"2003","unstructured":"Kane D, Stafford L, Bresnihan B, Fitzgerald O. A classification study of clinical subsets in an inception cohort of early psoriatic peripheral arthritis\u2014\u2018DIP or not DIP revisited. Rheumatol Oxf. 2003;42(12):1469\u201376.","journal-title":"Rheumatol Oxf"},{"issue":"8","key":"181_CR6","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1002\/art.21972","volume":"54","author":"W Taylor","year":"2006","unstructured":"Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 2006;54(8):2665\u201373.","journal-title":"Arthritis Rheum."},{"issue":"1","key":"181_CR7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1136\/ard.2006.054288","volume":"66","author":"PS Helliwell","year":"2007","unstructured":"Helliwell PS, Porter G, Taylor WJ. Polyarticular psoriatic arthritis is more like oligoarticular psoriatic arthritis, than rheumatoid arthritis. Ann Rheum Dis. 2007;66(1):113\u20137.","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"181_CR8","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1002\/1529-0131(199906)42:6<1080::AID-ANR2>3.0.CO;2-7","volume":"42","author":"D McGonagle","year":"1999","unstructured":"McGonagle D, Conaghan PG, Emery P. Psoriatic arthritis: a unified concept twenty years on. Arthritis Rheum. 1999;42(6):1080\u20136.","journal-title":"Arthritis Rheum."},{"issue":"8","key":"181_CR9","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1002\/art.22758","volume":"56","author":"D McGonagle","year":"2007","unstructured":"McGonagle D, Lories RJ, Tan AL, Benjamin M. The concept of a \u201csynovio-entheseal complex\u201d and its implications for understanding joint inflammation and damage in psoriatic arthritis and beyond. Arthritis Rheum. 2007;56(8):2482\u201391.","journal-title":"Arthritis Rheum."},{"issue":"4","key":"181_CR10","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1097\/BOR.0b013e32832c6ab9","volume":"21","author":"D McGonagle","year":"2009","unstructured":"\u2022McGonagle D, Benjamin M, Tan AL. The pathogenesis of psoriatic arthritis and associated nail disease: not autoimmune after all? Curr Opin Rheumatol. 2009;21(4):340\u20137. Together with the article by Benjamin and McGonagle [11\u2022], this overview nicely describes recent microanatomic and genetic studies of PsA, psoriasis, and psoriatic-associated nail disease, which leads to an alternative hypothesis for the pathophysiology of psoriatic disease, especially in the case of combined joint and nail disease.","journal-title":"Curr. Opin. Rheumatol."},{"key":"181_CR11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/978-1-4419-0298-6_4","volume":"649","author":"M Benjamin","year":"2009","unstructured":"\u2022Benjamin M, McGonagle D. The enthesis organ concept and its relevance to the spondyloarthropathies. Adv Exp Med Biol. 2009;649:57\u201370. This extensive review focuses on the inflammation at tendon or ligament attachment sites and proposes the concept of an enthesis organ. It highlights the fact that stress at an insertion site involves not only the enthesis itself, but neighboring tissues as well, including synovial tissue in bursae and joints. This emphasizes the interdependence between synovial membrane and entheses within enthesis organs. It draws attention to the fact that one component (the enthesis) is prone to microdamage and the other (the synovium) to inflammation.","journal-title":"Adv. Exp. Med. Biol."},{"issue":"11","key":"181_CR12","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1093\/rheumatology\/38.11.1074","volume":"38","author":"MC Kraan","year":"1999","unstructured":"Kraan MC, Haringman JJ, Post WJ, Versendaal J, Breedveld FC, Tak PP. Immunohistological analysis of synovial tissue for differential diagnosis in early arthritis. Rheumatol Oxf. 1999;38(11):1074\u201380.","journal-title":"Rheumatol Oxf"},{"issue":"2","key":"181_CR13","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1002\/art.20012","volume":"50","author":"D Baeten","year":"2004","unstructured":"Baeten D, Steenbakkers PG, Rijnders AM, Boots AM, Veys EM, De Keyser F. Detection of major histocompatibility complex\/human cartilage gp-39 complexes in rheumatoid arthritis synovitis as a specific and independent histologic marker. Arthritis Rheum. 2004;50(2):444\u201351.","journal-title":"Arthritis Rheum."},{"issue":"12","key":"181_CR14","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1002\/1529-0131(200012)43:12<2619::AID-ANR1>3.0.CO;2-V","volume":"43","author":"PP Tak","year":"2000","unstructured":"Tak PP, Bresnihan B. The pathogenesis and prevention of joint damage in rheumatoid arthritis: advances from synovial biopsy and tissue analysis. Arthritis Rheum. 2000;43(12):2619\u201333.","journal-title":"Arthritis Rheum."},{"issue":"12","key":"181_CR15","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1136\/ard.2005.050963","volume":"65","author":"AW Kuijk van","year":"2006","unstructured":"van Kuijk AW, Reinders-Blankert P, Smeets TJ, Dijkmans BA, Tak PP. Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatment. Ann Rheum Dis. 2006;65(12):1551\u20137.","journal-title":"Ann. Rheum. Dis."},{"key":"181_CR16","doi-asserted-by":"crossref","unstructured":"\u2022van Kuijk AW, Gerlag DM, Vos K, Wolbink G, de Groot M, de Rie MA et al. A prospective, randomised, placebo-controlled study to identify biomarkers associated with active treatment in psoriatic arthritis: effects of adalimumab treatment on synovial tissue. Ann Rheum Dis 2009; 68(8):1303-9. This prospective, placebo-controlled study was conducted to determine which of the changes in synovial tissue correlates best with clinical response associated with effective therapy in PsA. Adalimumab was used as a proven effective therapy, and synovial biopsies were obtained before and after 4 weeks of treatment. Using covariance analysis, it was shown that a significant effect of treatment was observed on reduction of synovial CD3 + T cells and MMP-13, suggesting that these parameters might be used as biomarkers that are sensitive to change after active treatment in small proof-of-concept studies in PsA.","DOI":"10.1136\/ard.2008.091389"},{"issue":"2","key":"181_CR17","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.berh.2008.02.002","volume":"22","author":"DM Gerlag","year":"2008","unstructured":"Gerlag DM, Tak PP. Novel approaches for the treatment of rheumatoid arthritis: lessons from the evaluation of synovial biomarkers in clinical trials. Best Pract Res Clin Rheumatol. 2008;22(2):311\u201323.","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"issue":"7","key":"181_CR18","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/art.1780360705","volume":"36","author":"D Veale","year":"1993","unstructured":"Veale D, Yanni G, Rogers S, Barnes L, Bresnihan B, Fitzgerald O. Reduced synovial membrane macrophage numbers, ELAM-1 expression, and lining layer hyperplasia in psoriatic arthritis as compared with rheumatoid arthritis. Arthritis Rheum. 1993;36(7):893\u2013900.","journal-title":"Arthritis Rheum."},{"issue":"7","key":"181_CR19","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1002\/1529-0131(199907)42:7<1481::AID-ANR23>3.0.CO;2-E","volume":"42","author":"RJ Reece","year":"1999","unstructured":"Reece RJ, Canete JD, Parsons WJ, Emery P, Veale DJ. Distinct vascular patterns of early synovitis in psoriatic, reactive, and rheumatoid arthritis. Arthritis Rheum. 1999;42(7):1481\u20134.","journal-title":"Arthritis Rheum."},{"issue":"9","key":"181_CR20","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1002\/1529-0131(200109)44:9<2024::AID-ART351>3.0.CO;2-K","volume":"44","author":"A Fraser","year":"2001","unstructured":"Fraser A, Fearon U, Reece R, Emery P, Veale DJ. Matrix metalloproteinase 9, apoptosis, and vascular morphology in early arthritis. Arthritis Rheum. 2001;44(9):2024\u20138.","journal-title":"Arthritis Rheum."},{"issue":"2","key":"181_CR21","first-page":"260","volume":"30","author":"U Fearon","year":"2003","unstructured":"Fearon U, Griosios K, Fraser A, Reece R, Emery P, Jones PF, et al. Angiopoietins, growth factors, and vascular morphology in early arthritis. J Rheumatol. 2003;30(2):260\u20138.","journal-title":"J. Rheumatol."},{"issue":"12","key":"181_CR22","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1136\/ard.59.12.945","volume":"59","author":"D Baeten","year":"2000","unstructured":"Baeten D, Demetter P, Cuvelier C, Van Den BF, Kruithof E, Van DN, et al. Comparative study of the synovial histology in rheumatoid arthritis, spondyloarthropathy, and osteoarthritis: influence of disease duration and activity. Ann Rheum Dis. 2000;59(12):945\u201353.","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"181_CR23","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1002\/1529-0131(200006)43:6<1244::AID-ANR7>3.0.CO;2-2","volume":"43","author":"CL Danning","year":"2000","unstructured":"Danning CL, Illei GG, Hitchon C, Greer MR, Boumpas DT, McInnes IB. Macrophage-derived cytokine and nuclear factor kappaB p65 expression in synovial membrane and skin of patients with psoriatic arthritis. Arthritis Rheum. 2000;43(6):1244\u201356.","journal-title":"Arthritis Rheum."},{"issue":"3","key":"181_CR24","doi-asserted-by":"publisher","first-page":"R569","DOI":"10.1186\/ar1698","volume":"7","author":"E Kruithof","year":"2005","unstructured":"Kruithof E, Baeten D, De RL, Vandooren B, Foell D, Roth J, et al. Synovial histopathology of psoriatic arthritis, both oligo- and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis. Arthritis Res Ther. 2005;7(3):R569\u201380.","journal-title":"Arthritis Res. Ther."},{"issue":"2","key":"181_CR25","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1136\/ard.2004.024430","volume":"64","author":"G Salvador","year":"2005","unstructured":"Salvador G, Sanmarti R, Garcia-Peiro A, Rodriguez-Cros JR, Munoz-Gomez J, Canete JD. p53 expression in rheumatoid and psoriatic arthritis synovial tissue and association with joint damage. Ann Rheum Dis. 2005;64(2):183\u20137.","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"181_CR26","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s11926-007-0071-5","volume":"9","author":"E Choy","year":"2007","unstructured":"Choy E. T cells in psoriatic arthritis. Curr Rheumatol Rep. 2007;9(6):437\u201341.","journal-title":"Curr. Rheumatol. Rep."},{"issue":"6","key":"181_CR27","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S0198-8859(99)00034-8","volume":"60","author":"I Tassiulas","year":"1999","unstructured":"Tassiulas I, Duncan SR, Centola M, Theofilopoulos AN, Boumpas DT. Clonal characteristics of T cell infiltrates in skin and synovium of patients with psoriatic arthritis. Hum Immunol. 1999;60(6):479\u201391.","journal-title":"Hum. Immunol."},{"issue":"1","key":"181_CR28","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.cyto.2009.10.005","volume":"49","author":"HA Flytlie","year":"2010","unstructured":"Flytlie HA, Hvid M, Lindgreen E, Kofod-Olsen E, Petersen EL, Jorgensen A, et al. Expression of MDC\/CCL22 and its receptor CCR4 in rheumatoid arthritis, psoriatic arthritis and osteoarthritis. Cytokine. 2010;49(1):24\u20139.","journal-title":"Cytokine"},{"issue":"7","key":"181_CR29","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1056\/NEJMoa021359","volume":"349","author":"VM Heydendael","year":"2003","unstructured":"Heydendael VM, Spuls PI, Opmeer BC, de Borgie CA, Reitsma JB, Goldschmidt WF, et al. Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis. N Engl J Med. 2003;349(7):658\u201365.","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"181_CR30","first-page":"2274","volume":"28","author":"C Salvarani","year":"2001","unstructured":"Salvarani C, Macchioni P, Olivieri I, Marchesoni A, Cutolo M, Ferraccioli G, et al. A comparison of cyclosporine, sulfasalazine, and symptomatic therapy in the treatment of psoriatic arthritis. J Rheumatol. 2001;28(10):2274\u201382.","journal-title":"J. Rheumatol."},{"issue":"5","key":"181_CR31","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1002\/art.21870","volume":"54","author":"PJ Mease","year":"2006","unstructured":"Mease PJ, Gladman DD, Keystone EC. Alefacept in combination with methotrexate for the treatment of psoriatic arthritis: results of a randomized, double-blind, placebo-controlled study. Arthritis Rheum. 2006;54(5):1638\u201345.","journal-title":"Arthritis Rheum."},{"key":"181_CR32","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1002\/art.30176","volume":"63","author":"P Mease","year":"2011","unstructured":"Mease P, Genovese MC, Gladstein G, Kivitz AJ, Ritchlin C, Tak PP, et al. Abatacept in the treatment of patients with psoriatic arthritis: results of a double-blind, randomized, placebo-controlled phase II trial. Arthritis Rheum. 2011;63:939\u201348.","journal-title":"Arthritis Rheum."},{"issue":"1","key":"181_CR33","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1084\/jem.20030451","volume":"199","author":"E Lee","year":"2004","unstructured":"Lee E, Trepicchio WL, Oestreicher JL, Pittman D, Wang F, Chamian F, et al. Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris. J Exp Med. 2004;199(1):125\u201330.","journal-title":"J. Exp. Med."},{"issue":"6","key":"181_CR34","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1038\/jid.2009.59","volume":"129","author":"CA Di","year":"2009","unstructured":"\u2022Di CA, Di MP, Nestle FO. The IL-23\/Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol. 2009;129(6):1339\u201350. This comprehensive review describes the recently recognized subset of IL-17\u2013producing T-helper cells named Th17 cells. In addition to a review of the development, characterization, and function of human Th17 cells, as well as the crucial role of IL-23 in the context of Th17-cell\u2013dependent chronic inflammation in psoriasis, recent clinical trials targeting the IL-23\/Th17 axis in psoriasis are discussed.","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"181_CR35","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/ar1478","volume":"7","author":"E Lubberts","year":"2005","unstructured":"Lubberts E, Koenders MI, van den Berg WB. The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models. Arthritis Res Ther. 2005;7(1):29\u201337.","journal-title":"Arthritis Res. Ther."},{"issue":"3","key":"181_CR36","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1136\/ard.2009.107649","volume":"69","author":"L Melis","year":"2010","unstructured":"Melis L, Vandooren B, Kruithof E, Jacques P, De VM, Mielants H, et al. Systemic levels of IL-23 are strongly associated with disease activity in rheumatoid arthritis but not spondyloarthritis. Ann Rheum Dis. 2010;69(3):618\u201323.","journal-title":"Ann. Rheum. Dis."},{"issue":"9664","key":"181_CR37","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/S0140-6736(09)60140-9","volume":"373","author":"A Gottlieb","year":"2009","unstructured":"Gottlieb A, Menter A, Mendelsohn A, Shen YK, Li S, Guzzo C, et al. Ustekinumab, a human interleukin 12\/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial. Lancet. 2009;373(9664):633\u201340.","journal-title":"Lancet"},{"issue":"6","key":"181_CR38","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1136\/ard.2006.062042","volume":"66","author":"JD Canete","year":"2007","unstructured":"Canete JD, Santiago B, Cantaert T, Sanmarti R, Palacin A, Celis R, et al. Ectopic lymphoid neogenesis in psoriatic arthritis. Ann Rheum Dis. 2007;66(6):720\u20136.","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"181_CR39","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/1523-1747.ep12485169","volume":"68","author":"IM Braverman","year":"1977","unstructured":"Braverman IM, Yen A. Ultrastructure of the capillary loops in the dermal papillae of psoriasis. J Invest Dermatol. 1977;68(1):53\u201360.","journal-title":"J. Invest. Dermatol."},{"issue":"6","key":"181_CR40","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1053\/sarh.2002.50004","volume":"32","author":"JD Canete","year":"2003","unstructured":"Canete JD, Rodriguez JR, Salvador G, Gomez-Centeno A, Munoz-Gomez J, Sanmarti R. Diagnostic usefulness of synovial vascular morphology in chronic arthritis. A systematic survey of 100 cases. Semin Arthritis Rheum. 2003;32(6):378\u201387.","journal-title":"Semin. Arthritis Rheum."},{"issue":"3","key":"181_CR41","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1084\/jem.180.3.1141","volume":"180","author":"M Detmar","year":"1994","unstructured":"Detmar M, Brown LF, Claffey KP, Yeo KT, Kocher O, Jackman RW, et al. Overexpression of vascular permeability factor\/vascular endothelial growth factor and its receptors in psoriasis. J Exp Med. 1994;180(3):1141\u20136.","journal-title":"J. Exp. Med."},{"issue":"1","key":"181_CR42","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/art.1780390118","volume":"39","author":"C Pitzalis","year":"1996","unstructured":"Pitzalis C, Cauli A, Pipitone N, Smith C, Barker J, Marchesoni A, et al. Cutaneous lymphocyte antigen-positive T lymphocytes preferentially migrate to the skin but not to the joint in psoriatic arthritis. Arthritis Rheum. 1996;39(1):137\u201345.","journal-title":"Arthritis Rheum."},{"issue":"1","key":"181_CR43","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1136\/ard.2008.090548","volume":"69","author":"AW Kuijk van","year":"2010","unstructured":"van Kuijk AW, Wijbrandts CA, Vinkenoog M, Zheng TS, Reedquist KA, Tak PP. TWEAK and its receptor Fn14 in the synovium of patients with rheumatoid arthritis compared to psoriatic arthritis and its response to tumour necrosis factor blockade. Ann Rheum Dis. 2010;69(1):301\u20134.","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"181_CR44","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/j.1365-3083.2009.02266.x","volume":"70","author":"M Westman","year":"2009","unstructured":"\u2022Westman M, Engstrom M, Catrina AI, Lampa J. Cell specific synovial expression of nicotinic alpha 7 acetylcholine receptor in rheumatoid arthritis and psoriatic arthritis. Scand J Immunol. 2009;70(2):136\u201340. The cholinergic anti-inflammatory pathway is characterized by neural regulation of systemic inflammation, mediated by the vagus nerve and specific cholinergic stimulation of the nicotinic \u03b17nAChR on immune cells. This study demonstrated the expression and localization of \u03b17nAChR in synovial biopsies from patients with RA and PsA, indicating a potential role for \u03b17nAChR in arthritis pathogenesis and implicating specific cholinergic modulation as a potential anti-inflammatory therapeutic strategy in joint inflammation.","journal-title":"Scand. J. Immunol."},{"issue":"2","key":"181_CR45","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.semarthrit.2009.03.002","volume":"40","author":"MF Seidel","year":"2010","unstructured":"\u2022Seidel MF, Herguijuela M, Forkert R, Otten U. Nerve growth factor in rheumatic diseases. Semin Arthritis Rheum. 2010;40(2):109\u201326. There is considerable evidence to indicate that NGF acts as an important mediator of immune responses. This article reviews the role of NGF in neurogenic inflammation, especially rheumatic diseases, and strategies for potential therapeutic interventions.","journal-title":"Semin. Arthritis Rheum."},{"issue":"10","key":"181_CR46","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.1002\/art.20518","volume":"50","author":"D Kane","year":"2004","unstructured":"Kane D, Gogarty M, O\u2019Leary J, Silva I, Bermingham N, Bresnihan B, et al. Reduction of synovial sublining layer inflammation and proinflammatory cytokine expression in psoriatic arthritis treated with methotrexate. Arthritis Rheum. 2004;50(10):3286\u201395.","journal-title":"Arthritis Rheum."},{"issue":"6","key":"181_CR47","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1002\/art.21914","volume":"54","author":"E Kruithof","year":"2006","unstructured":"Kruithof E, De RL, Vandooren B, De KF, Fitzgerald O, McInnes I, et al. Identification of synovial biomarkers of response to experimental treatment in early-phase clinical trials in spondylarthritis. Arthritis Rheum. 2006;54(6):1795\u2013804.","journal-title":"Arthritis Rheum."},{"issue":"10","key":"181_CR48","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1002\/art.10543","volume":"46","author":"MC Kraan","year":"2002","unstructured":"Kraan MC, van Kuijk AW, Dinant HJ, Goedkoop AY, Smeets TJ, de Rie MA, et al. Alefacept treatment in psoriatic arthritis: reduction of the effector T cell population in peripheral blood and synovial tissue is associated with improvement of clinical signs of arthritis. Arthritis Rheum. 2002;46(10):2776\u201384.","journal-title":"Arthritis Rheum."},{"issue":"7","key":"181_CR49","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1136\/ard.2003.018085","volume":"63","author":"AY Goedkoop","year":"2004","unstructured":"Goedkoop AY, Kraan MC, Teunissen MB, Picavet DI, de Rie MA, Bos JD, et al. Early effects of tumour necrosis factor alpha blockade on skin and synovial tissue in patients with active psoriasis and psoriatic arthritis. Ann Rheum Dis. 2004;63(7):769\u201373.","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"181_CR50","doi-asserted-by":"publisher","first-page":"R326","DOI":"10.1186\/ar1182","volume":"6","author":"AY Goedkoop","year":"2004","unstructured":"Goedkoop AY, Kraan MC, Picavet DI, de Rie MA, Teunissen MB, Bos JD, et al. Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study. Arthritis Res Ther. 2004;6(4):R326\u201334.","journal-title":"Arthritis Res. Ther."},{"issue":"5","key":"181_CR51","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1002\/art.20181","volume":"50","author":"JD Canete","year":"2004","unstructured":"Canete JD, Pablos JL, Sanmarti R, Mallofre C, Marsal S, Maymo J, et al. Antiangiogenic effects of anti-tumor necrosis factor alpha therapy with infliximab in psoriatic arthritis. Arthritis Rheum. 2004;50(5):1636\u201341.","journal-title":"Arthritis Rheum."},{"issue":"7","key":"181_CR52","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.4049\/jimmunol.167.7.4075","volume":"167","author":"IB McInnes","year":"2001","unstructured":"McInnes IB, Illei GG, Danning CL, Yarboro CH, Crane M, Kuroiwa T, et al. IL-10 improves skin disease and modulates endothelial activation and leukocyte effector function in patients with psoriatic arthritis. J Immunol. 2001;167(7):4075\u201382.","journal-title":"J. Immunol."},{"issue":"12","key":"181_CR53","doi-asserted-by":"publisher","first-page":"3783","DOI":"10.1002\/art.20664","volume":"50","author":"DM Gerlag","year":"2004","unstructured":"Gerlag DM, Haringman JJ, Smeets TJ, Zwinderman AH, Kraan MC, Laud PJ, et al. Effects of oral prednisolone on biomarkers in synovial tissue and clinical improvement in rheumatoid arthritis. Arthritis Rheum. 2004;50(12):3783\u201391.","journal-title":"Arthritis Rheum."},{"issue":"1","key":"181_CR54","doi-asserted-by":"publisher","first-page":"R7","DOI":"10.1186\/ar3228","volume":"13","author":"EK Pontifex","year":"2011","unstructured":"Pontifex EK, Gerlag DM, Gogarty M, Vinkenoog M, Gibbs A, Burgman I, et al. Change in CD3 positive T-cell expression in psoriatic arthritis synovium correlates with change in DAS28 and magnetic resonance imaging synovitis scores following initiation of biologic therapy\u2014a single centre, open-label study. Arthritis Res Ther. 2011;13(1):R7.","journal-title":"Arthritis Res. Ther."},{"issue":"5","key":"181_CR55","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1136\/ard.2009.113233","volume":"69","author":"JD Canete","year":"2010","unstructured":"Canete JD, Celis R, Hernandez V, Pablos JL, Sanmarti R. Synovial immunopathological changes associated with successful abatacept therapy in a case of severe refractory psoriatic arthritis. Ann Rheum Dis. 2010;69(5):935\u20136.","journal-title":"Ann. Rheum. Dis."},{"key":"181_CR56","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1136\/ard.2010.139550","volume":"70","author":"MG Sande van de","year":"2011","unstructured":"van de Sande MG, Gerlag DM, Lodde BM, van Baarsen LG, Alivernini S, Codullo V, et al. Evaluating antirheumatic treatments using synovial biopsy: a recommendation for standardisation to be used in clinical trials. Ann Rheum Dis. 2011;70:423\u20137.","journal-title":"Ann. Rheum. Dis."}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-011-0181-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-011-0181-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-011-0181-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-011-0181-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,9]],"date-time":"2019-06-09T23:41:36Z","timestamp":1560123696000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-011-0181-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,19]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["181"],"URL":"https:\/\/doi.org\/10.1007\/s11926-011-0181-y","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,19]]}}}